| Autor: |
Souto NS; Programa de Pós-Graduação em Ciência e Tecnologia dos Alimentos, Universidade Federal de Santa Maria, Santa Maria, Brasil., Dassi M; Programa de Pós-Graduação em Ciência e Tecnologia dos Alimentos, Universidade Federal de Santa Maria, Santa Maria, Brasil., Braga ACM; Programa de Pós-Graduação em Farmacologia, Universidade Federal de Santa Maria, Santa Maria, Brasil., Rosa ÉVF; Programa de Pós-Graduação em Farmacologia, Universidade Federal de Santa Maria, Santa Maria, Brasil., Fighera MR; Programa de Pós-Graduação em Farmacologia, Universidade Federal de Santa Maria, Santa Maria, Brasil., Royes LFF; Programa de Pós-Graduação em Farmacologia, Universidade Federal de Santa Maria, Santa Maria, Brasil., Oliveira MS; Programa de Pós-Graduação em Farmacologia, Universidade Federal de Santa Maria, Santa Maria, Brasil., Sari MHM; Programa de Pós-Graduação em Farmacologia, Universidade Federal de Santa Maria, Santa Maria, Brasil., Furian AF; Programa de Pós-Graduação em Ciência e Tecnologia dos Alimentos, Universidade Federal de Santa Maria, Santa Maria, Brasil.; Programa de Pós-Graduação em Farmacologia, Universidade Federal de Santa Maria, Santa Maria, Brasil. |
| Abstrakt: |
The potential interactions among food additives/contaminants and the consequences to biological systems is a topic that is rarely addressed in scientific literature. Thus, the current study investigated if the combined administration of ASP and AFB 1 would impair hepatic and renal oxidative status. Male Wistar rats received during 14 days once a day ASP (75 mg/Kg) and/or AFB 1 (250 µg/Kg) through intragastric route. At the end of experimental protocol, samples of liver and kidneys were collected for assessing biochemical markers of oxidative status. In the hepatic tissue, the treatment with a single substance (ASP or AFB 1 ) caused an increase in TBARS levels, and a reduction in non-enzymatic antioxidant defenses (Vit C and NPSH levels and FRAP test). In the kidneys, TBARS levels were increased only in the group that received ASP + AFB 1 . The association reduced NPSH content, while the treatment with AFB 1 reduced the FRAP levels. GST and CAT activities were increased in all treatments. Overall, ASP and AFB1 association presented higher toxic effects to the tissues. To the best of our knowledge, this is the first study demonstrating that the associated use of both ASP and AFB1 induces more extensive injuries in comparison to the effects caused by each one alone. Therefore, these data demonstrated that concomitant exposure to ASP and AFB 1 potentiated their oxidative damage in hepatic tissue, suggesting that this organ is particularly sensitive to the toxic action induced by these substances. |
